Sustained Β-catenin activity in dermal fibroblasts is sufficient for skin fibrosis

Journal of Investigative Dermatology

Volumn 132, Issue 10, 2012, Pages 2469-2472

  Hamburg, Emily J ^a   Atit, Radhika P ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; EMBRYO; FIBROGENESIS; IMMUNOREACTIVITY; LETTER; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERODERMA; SKIN FIBROBLAST; SKIN FIBROSIS;

EID: 84866393033     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.155     Document Type: Letter

References (16)

1. Akhmetshina A, Palumbo K, Dees C et al. (2012) Activation of canonical Wnt signalling is required for TGF-b-mediated fibrosis. Nat Commun 3:735
2. Alman BA, Li C, Pajerski ME et al. (1997) Increased b-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 151:329
3. Bayle J, Fitch J, Jacobsen K et al. (2008) Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis. J Invest Dermatol 128: 871-81 (Pubitemid 351374297)
4. Bergmann C, Akhmetshina A, Dees C et al. (2011) Inhibition of glycogen synthase kinase 3b induces dermal fibrosis by activation of the canonical Wnt pathway. Ann Rheum Dis 70:2191-8
5. Beyer C, Schramm A, Akhmetshina A et al. (2012) b-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis. Ann Rheum Dis 71:761-7
6. Bowley E, O'Gorman DB, Gan BS (2007) bcatenin signaling in fibroproliferative disease. J Surg Res 138:141-50
7. Harada N, Tamai Y, Ishikawa T et al. (1999) Intestinal polyposis in mice with a dominant stable mutation of the b-catenin gene. EMBO J 18:5931-42 (Pubitemid 29515670)
8. Holmes A, Abraham DJ, Sa S et al. (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276:10594-601 (Pubitemid 38089227)
9. Lam AP, Gottardi CJ. (2011) b-Catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol 23:562-7
10. Nguyen M-T, Zhu J, Nakamura E et al. (2009) Tamoxifen-dependent, inducible Hoxb6-CreERT recombinase function in lateral plate and limb mesoderm, CNS isthmic organizer, posterior trunk neural crest, hindgut, and tailbud. Dev Dyn 238:467-74
11. Ohtola J, Myers J, Akhtar-Zaidi B et al. (2008) b-Catenin has sequential roles in the survival and specification of ventral dermis. Development 135:2321-9
12. Sato M. (2006) Upregulation of the Wnt/b-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol 86:300-7 (Pubitemid 44133374)
13. Srinivas S, Watanabe T, Lin CS et al. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1:4
14. van Amerongen R, Nusse R. (2009) Towards an integrated view of Wnt signaling in development. Development 136:3205-14
15. Wei J, Fang F, Lam AP et al. (2012) Wnt/b-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells. Arthritis Rheum; e-pub ahead of print 10 February 2012
16. Wei J, Melichian D, Komura K et al. (2011) Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum 63:1707-17